MediPharm Labs (LABS) Competitors C$0.07 -0.01 (-12.50%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. CRDL, RX, HLS, TGOD, NINE, SUGR, WMD, MDP, HEXO, and VIRShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Cardiol Therapeutics (CRDL), BioSyent (RX), HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), HEXO (HEXO), and Viridium Pacific Group (VIR). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Cardiol Therapeutics BioSyent HLS Therapeutics Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers WeedMD Medexus Pharmaceuticals HEXO Viridium Pacific Group MediPharm Labs (TSE:LABS) and Cardiol Therapeutics (TSE:CRDL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations. Which has higher valuation and earnings, LABS or CRDL? MediPharm Labs has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediPharm LabsC$39.42M0.74-C$12.05M-C$0.03-2.41Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-2.89 Which has more risk and volatility, LABS or CRDL? MediPharm Labs has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Do institutionals & insiders have more ownership in LABS or CRDL? 0.7% of MediPharm Labs shares are owned by institutional investors. Comparatively, 11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Comparatively, 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is LABS or CRDL more profitable? Cardiol Therapeutics has a net margin of 0.00% compared to MediPharm Labs' net margin of -30.56%. MediPharm Labs' return on equity of -24.41% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MediPharm Labs-30.56% -24.41% -7.17% Cardiol Therapeutics N/A -195.07%-54.15% Does the media refer more to LABS or CRDL? In the previous week, MediPharm Labs had 1 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 1 mentions for MediPharm Labs and 0 mentions for Cardiol Therapeutics. MediPharm Labs' average media sentiment score of 1.11 beat Cardiol Therapeutics' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media. Company Overall Sentiment MediPharm Labs Positive Cardiol Therapeutics Neutral Does the MarketBeat Community believe in LABS or CRDL? MediPharm Labs received 16 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote. CompanyUnderperformOutperformMediPharm LabsOutperform Votes2565.79% Underperform Votes1334.21% Cardiol TherapeuticsOutperform Votes969.23% Underperform Votes430.77% SummaryMediPharm Labs beats Cardiol Therapeutics on 10 of the 14 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$29.05MC$2.17BC$5.35BC$5.94BDividend YieldN/A2.92%5.22%6.32%P/E Ratio-2.413.9826.8429.95Price / Sales0.74529.96391.39752.53Price / Cash1.3010.2538.2583.71Price / Book0.646.926.793.96Net Income-C$12.05MC$20.70BC$3.23BC$301.32M7 Day PerformanceN/A0.55%4.07%1.35%1 Month PerformanceN/A5.30%12.52%8.57%1 Year PerformanceN/A91.10%16.83%14.85% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07-12.5%N/A+0.0%C$29.05MC$39.42M-2.41130Positive NewsHigh Trading VolumeCRDLCardiol TherapeuticsN/AC$1.61+1.3%N/A-47.1%C$133.60MN/A-3.1620RXBioSyentN/AC$10.80-0.7%N/A+30.0%C$123.52MC$34.06M17.53N/ANews CoverageAnalyst RevisionHLSHLS Therapeutics0.5871 of 5 starsC$4.68+4.0%C$4.50-3.8%+21.3%C$104.12MC$40.13M-4.6991Gap UpTGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpSUGRSugarBud Craft GrowersN/AC$12.00-2.0%N/A+10,572.7%C$81.84MC$575.64M14.4644Gap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus Pharmaceuticals1.5948 of 5 starsC$2.59-5.1%C$5.49+111.9%+61.3%C$57.99MC$100.25M12.3998HEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up Related Companies and Tools Related Companies Cardiol Therapeutics Competitors BioSyent Competitors HLS Therapeutics Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors HEXO Competitors Viridium Pacific Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABS Stock Free LABS Stock Alerts